Published on: 16 June 2021 Roche statement on the preliminary phase III data from UK University of Oxford-led RECOVERY trial for casirivimab and imdevimab Downloads: Download
Published on: 12 March 2021 Roche statement on FDA Oncologic Drug Advisory Meetings on 27–29 April 2021 Downloads: Download
Published on: 1 February 2021 Roche statement on the European Medicines Agency (EMA) commencement of review for Regeneron’s antibody cocktail (casirivimab and imdevimab) Downloads: Download
Published on: 26 January 2021 Roche statement on casirivimab and imdevimab data in preventing COVID-19 infections within households Downloads: Download
Published on: 30 December 2020 Roche statement on casirivimab and imdevimab data in hospitalised patients Downloads: Download
Published on: 23 December 2020 Roche statement on new variants of SARS-CoV-2 found in the UK Downloads: Download
Published on: 22 November 2020 Roche statement on FDA acceptance of casirivimab and imdevimab (REGNCOV2) EUA in the US Downloads: Download
Published on: 30 October 2020 Changes recommended to ongoing REGN-COV2 study in hospitalized patients by Independent Data Monitoring Committee Downloads: Download
Published on: 28 October 2020 Roche statement on REGN-COV2 data in non-hospitalised patients Downloads: Download
Published on: 8 October 2020 Roche statement on REGN-COV2 US Emergency Use Authorization Request Downloads: Download
Published on: 7 October 2020 Roche statement regarding UK diagnostics products supply issue Downloads: Download
Published on: 29 September 2020 Roche statement on REGN-COV2 virology phase II data Downloads: Download
